Centogene N.V. is a company that focuses on rare diseases, transforming clinical and genetic data into usable information for various stakeholders. Its services include genetic sequencing and diagnostics, COVID-19 testing solutions, epidemiological insights and patient monitoring. Founded in 2006, it has collaboration and license agreements with several global pharmaceutical companies and is headquartered in Rostock, Germany.